PhotonPharma Inc., a developer of autologous cancer immunotherapies that recently secured $2.5 million in seed funding, has appointed Derek Brown as its new Chief Executive Officer.   With more than 25 years of diverse biopharmaceutical experience across the entire product lifecycle, Brown brings a wealth of strategic, operational, and financial expertise to guide PhotonPharma through its next phase of growth. He replaces Alan Rudolph who will step down after leading the company to a successfu...